Open AccessBioequivalence assessment of two formulations of ibuprofen
Author(s) -
Zeyad A. AlTalla,
Sabah H. Akrawi,
Tolley,
Zaater,
Emwas,
Sioud
Publication year - 2011
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s24504
Subject(s) - bioequivalence , ibuprofen , pharmacokinetics , bioavailability , confidence interval , chromatography , medicine , dosing , pharmacology , chemistry
This study assessed the relative bioavailability of two formulations of ibuprofen. The first formulation was Doloraz(®), produced by Al-Razi Pharmaceutical Company, Amman, Jordan. The second forumulation was Brufen(®), manufactured by Boots Company, Nottingham, UK.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom